MTC Podcasts

Rare Care podcast logo

An Interview With Abigail Jenkins, President and CEO of Gamida Cell

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Abigail Jenkins, president and CEO of Gamida Cell, on the company’s development of omidubicel as an alternative to umbilical cord blood in stem cell transplants for myelofibrosis and other diseases. Read the full story here: Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem…

Next hm-quiz in MTC Quizzes